W. Butscher

Coordinate Transactivation of the Interleukin-2 CD28 Response Element by c-Rel and ATF-1/CREB2*

W. Butscher, C. Powers, M. Olive, 1998, The Journal of Biological Chemistry.

The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up‐regulation in rat la fibroblasts

M. Raffeld, W. Butscher, K. Gardner, 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Selective Inhibition of Mitogen-induced Transactivation of the HIV Long Terminal Repeat by Carboxyamidotriazole

E. Kohn, L. Liotta, W. Butscher, 1997, The Journal of Biological Chemistry.

The therapeutic action of monoclonal antibodies against a surface glycoprotein of Giardia muris.

W. Butscher, G. Faubert, 1988, Immunology.

Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment.

Kevin Gardner, Irene Collins, Idalia Montano, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Targeting Combinatorial Transcriptional Complex Assembly at Specific Modules within the Interleukin-2 Promoter by the Immunosuppressant SB203580*

K. Gardner, C. Haggerty, W. Butscher, 2003, Journal of Biological Chemistry.

Targeting of p300 to the Interleukin-2 Promoter via CREB-Rel Cross-talk during Mitogen and Oncogenic Molecular Signaling in Activated T-cells*

C. Haggerty, W. Butscher, K. Gardner, 2001, The Journal of Biological Chemistry.

Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene

K. Gardner, C. Haggerty, W. Butscher, 2002, The Journal of Immunology.

Modification of a nonincinerative method for determination of iodine in iodoproteins.

W. Butscher, N. Rose, A. Saboori, 1993, Analytical biochemistry.

Immunoreactivity of multiple molecular forms of human thyroglobulin.

W. Butscher, N. Rose, A. Saboori, 1994, Clinical Immunology and Immunopathology.